SCHEMBL6690537

SCHEMBL6690537

CCN1CCCN(C(=O)c2ccc(C)c(C(N)=O)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.48
TSHR P16473 1/20 0.47
KMT2A Q03164 2/20 0.46
HRH3 Q9Y5N1 1/20 0.46
GRIN2B Q13224 2/20 0.46
PLA2G7 Q13093 1/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 5/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
PARP1 P09874 1/20 0.45
MEN1 O00255 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPBWR1 P48145 1/20 0.43
CHKA P35790 1/20 0.43
POLB P06746 2/20 0.43
CNR2 P34972 1/20 0.43
CYP2C19 P33261 1/20 0.43
ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3226312 0.95 ALDH1A1 (0.48) HPGDTSHRKMT2AALDH1A1SMN1; SMN2
SCHEMBL6687780 0.91 PARP1 (0.46) HPGDTSHRKMT2AGRIN2BPLA2G7
SCHEMBL6687434 0.89 HPGD (0.44) HPGDTSHRKMT2AHRH3GRIN2B
SCHEMBL6688446 0.86 PARP1 (0.46) HPGDTSHRKMT2AHRH3GRIN2B
SCHEMBL3234941 0.86 ALDH1A1 (0.49) HPGDTSHRKMT2AALDH1A1SMN1; SMN2
SCHEMBL6690538 0.85 HPGD (0.50) HPGDTSHRKMT2AHRH3GRIN2B
SCHEMBL6688045 0.81 PARP1 (0.54) HPGDTSHRKMT2AHRH3GRIN2B
SCHEMBL3231384 0.80 KMT2A (0.56) HPGDTSHRKMT2AALDH1A1MEN1
SCHEMBL2377312 0.79 ALDH1A1 (0.50) HPGDTSHRKMT2AALDH1A1SMN1; SMN2
SCHEMBL3226386 0.77 ALDH1A1 (0.56) HPGDKMT2AALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004074438-A2 CCR8 ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2004-09-02 WO claimed
WO-2004074438-A2 CCR8 ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2004-09-02 WO disclosed